Literature DB >> 11299328

Walker-256 tumor growth causes oxidative stress in rat brain.

J J Freitas1, C Pompéia, C K Miyasaka, R Curi.   

Abstract

The elevated rate of oxygen consumption and high amount of polyunsaturated fatty acids make the central nervous system vulnerable to oxidative stress. The effect of Walker-256 tumor growth on oxi-reduction indexes in the hypothalamus (HT), cortex (CT), hippocampus (HC) and cerebellum (CB) of male Wistar rats was investigated. The presence of the tumor caused an increase in thiobarbituric acid reactant substances (TBARs) in the HT, CB and HC. Due to tumor growth, the activity of glucose-6-phosphate dehydrogenase increased in the HT and CB, whereas citrate synthase activity was reduced in the HT, CT and CB. Therefore, the potential for generation of reducing power is increased in the cytosol and decreased in the mitochondria of various brain regions of Walker-256 tumor-bearing rats. These changes occurred concomitantly with an unbalance in the brain enzymatic antioxidant system. The tumor decreased the activities of catalase in the HT and CB and of glutathione peroxidase in the HT, CB and HC, and raised the CuZn-superoxide dismutase activity in the HT, CB and HC. These combined findings indicate that Walker-256 tumor growth causes oxidative stress in the brain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11299328     DOI: 10.1046/j.1471-4159.2001.00280.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  Age-related changes in nitric oxide activity, cyclic GMP, and TBARS levels in platelets and erythrocytes reflect the oxidative status in central nervous system.

Authors:  Elisa Mitiko Kawamoto; Andrea Rodrigues Vasconcelos; Sabrina Degaspari; Ana Elisa Böhmer; Cristoforo Scavone; Tania Marcourakis
Journal:  Age (Dordr)       Date:  2012-01-26

2.  Altered KLOTHO and NF-κB-TNF-α Signaling Are Correlated with Nephrectomy-Induced Cognitive Impairment in Rats.

Authors:  Sabrina Degaspari; Carmen Branco Tzanno-Martins; Clarice Kazue Fujihara; Roberto Zatz; João Paulo Branco-Martins; Tania Araujo Viel; Hudson de Souza Buck; Ana Maria Marques Orellana; Ana Elisa Böhmer; Larissa de Sá Lima; Diana Zukas Andreotti; Carolina Demarchi Munhoz; Cristoforo Scavone; Elisa Mitiko Kawamoto
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

3.  Experimental Cancer Cachexia Changes Neuron Numbers and Peptide Levels in the Intestine: Partial Protective Effects after Dietary Supplementation with L-Glutamine.

Authors:  Geraldo E Vicentini; Luciane Fracaro; Sara R G de Souza; Heber A Martins; Flávia A Guarnier; Jacqueline N Zanoni
Journal:  PLoS One       Date:  2016-09-16       Impact factor: 3.240

4.  The anorexigenic effect of serotonin is mediated by the generation of NADPH oxidase-dependent ROS.

Authors:  Xin-Ling Fang; Gang Shu; Jian-Jian Yu; Li-Na Wang; Jing Yang; Qing-Jie Zeng; Xiao Cheng; Zhi-Qi Zhang; Song-Bo Wang; Ping Gao; Xiao-Tong Zhu; Qian-Yun Xi; Yong-Liang Zhang; Qing-Yan Jiang
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

Review 5.  Contribution of Neuroinflammation to the Pathogenesis of Cancer Cachexia.

Authors:  Alessio Molfino; Gianfranco Gioia; Filippo Rossi Fanelli; Alessandro Laviano
Journal:  Mediators Inflamm       Date:  2015-10-04       Impact factor: 4.711

6.  The antioxidant response induced by Lonicera caerulaea berry extracts in animals bearing experimental solid tumors.

Authors:  Maria Iuliana Gruia; Eliza Oprea; Ion Gruia; Valentina Negoita; Ileana Cornelia Farcasanu
Journal:  Molecules       Date:  2008-03-27       Impact factor: 4.411

7.  Brain metabolites in cholinergic and glutamatergic pathways are altered by pancreatic cancer cachexia.

Authors:  Paul T Winnard; Santosh Kumar Bharti; Raj Kumar Sharma; Balaji Krishnamachary; Yelena Mironchik; Marie-France Penet; Michael G Goggins; Anirban Maitra; Ihab Kamel; Karen M Horton; Michael A Jacobs; Zaver M Bhujwalla
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-10-02       Impact factor: 12.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.